A Study of Venetoclax in Combination With Azacitidine Versus Azacitidine in Treatment NaĂŻve Participants With Acute Myeloid Leukemia Who Are Ineligible for Standard Induction Therapy
PHASE3
Acute Myeloid Leukaemia (AML) is an aggressive and rare cancer of myeloid c...
A Multi-Site Break Through Cancer Trial: Targeting Measurable Residual Disease in Patients With Acute Myeloid Leukemia: A Phase 1/2 Study of Tagraxofusp, Azacitidine, and Venetoclax
PHASE1
The purpose of this research study is to test the safety and efficacy of a ...
A PALG Prospective Multicenter Clinical Trial to Compare the Efficacy of Two Standard Induction Therapies (DA-90 vs DAC) and Two Standard Salvage Regimens (FLAG-IDA vs CLAG-M) in AML Patients †60 Years Old
PHASE3
The study will include newly-diagnosed AML patients, not suffering acute pr...